Hiroaki Nishikawa Selected Research

C-Reactive Protein

3/2023	Association between major adverse cardiovascular events and pentraxin-3 in patients who have undergone coronary computed tomography angiography: from the FU-CCTA registry.
1/2006	Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroaki Nishikawa Research Topics

Disease

27	Coronary Artery Disease (Coronary Atherosclerosis) 03/2023 - 11/2002
13	Myocardial Infarction 08/2016 - 07/2002
12	Pathologic Constriction (Stenosis) 01/2017 - 10/2003
10	Stable Angina 02/2018 - 07/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 07/2002
8	Atherosclerosis 02/2021 - 01/2004
6	Coronary Restenosis 08/2016 - 10/2003
5	Coronary Stenosis (Coronary Artery Stenosis) 11/2020 - 10/2003
5	Acute Coronary Syndrome 02/2018 - 01/2005
5	Diabetes Mellitus 08/2016 - 01/2011
4	Hypertension (High Blood Pressure) 02/2021 - 02/2004
4	Thrombosis (Thrombus) 02/2013 - 12/2009
3	Heart Failure 05/2017 - 01/2006
2	Dyslipidemias (Dyslipidemia) 02/2021 - 12/2020
2	Hypercholesterolemia 09/2009 - 12/2008
1	Inflammation (Inflammations) 03/2023
1	Body Weight (Weight, Body) 05/2017
1	Neoplasms (Cancer) 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2017
1	Anterior Wall Myocardial Infarction 07/2016
1	Hyperglycemia 05/2015
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 12/2014
1	Pulmonary Hypertension 12/2014
1	Atherosclerotic Plaque (Atheroma) 01/2013
1	Chest Pain (Chest Pains) 04/2012
1	Hypoadiponectinemia 11/2011
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2011
1	Rupture 01/2008
1	Hyperlipidemias (Hyperlipidemia) 01/2005

Drug/Important Bio-Agent (IBA)

12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2020 - 02/2004
8	LDL CholesterolIBA 02/2021 - 01/2006
8	LipidsIBA 11/2020 - 01/2006
6	oxidized low density lipoproteinIBA 02/2021 - 12/2008
5	CholesterolIBA 01/2017 - 09/2006
4	HDL CholesterolIBA 02/2021 - 06/2009
4	Angiotensin Receptor AntagonistsIBA 05/2017 - 03/2005
3	Triglycerides (Triacylglycerol)IBA 02/2021 - 06/2009
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2017 - 06/2003
3	olmesartanIBA 01/2013 - 07/2009
3	AdiponectinIBA 11/2011 - 02/2009
3	Valsartan (Vals)FDA Link 09/2011 - 01/2007
3	Chemokine ReceptorsIBA 01/2008 - 10/2003
3	ChemokinesIBA 01/2008 - 10/2003
2	C-Reactive ProteinIBA 03/2023 - 01/2006
2	Hemoglobins (Hemoglobin)IBA 02/2021 - 06/2009
2	HDL LipoproteinsIBA 08/2016 - 05/2003
2	MetalsIBA 08/2016 - 01/2008
2	omega-Chloroacetophenone (Mace)IBA 02/2015 - 01/2011
2	Atorvastatin (Lipitor)FDA Link 08/2012 - 08/2012
2	Angiotensin II Type 1 Receptor BlockersIBA 07/2009 - 03/2006
2	Pravastatin (Pravachol)FDA LinkGeneric 12/2008 - 11/2002
2	Cell Adhesion MoleculesIBA 01/2004 - 01/2004
1	Blood Glucose (Blood Sugar)IBA 02/2021
1	von Willebrand FactorIBA 04/2018
1	Coloring Agents (Dyes)IBA 04/2018
1	Tolvaptan FDA Link 05/2017
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2017
1	DiamondIBA 10/2016
1	Amlodipine (Norvasc)FDA LinkGeneric 10/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2015
1	Insulin (Novolin)FDA Link 05/2015
1	Bosentan (Tracleer)FDA Link 12/2014
1	Gallium-68IBA 01/2013
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2013
1	apolipoprotein A-I MilanoIBA 01/2013
1	Irbesartan FDA LinkGeneric 01/2013
1	ApolipoproteinsIBA 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2013
1	PTX3 proteinIBA 08/2012
1	Ezetimibe (Zetia)FDA Link 08/2012
1	Glycated Serum AlbuminIBA 01/2012
1	pentosidineIBA 09/2011
1	pigment epithelium-derived factorIBA 09/2011
1	Biomarkers (Surrogate Marker)IBA 09/2011
1	BilirubinIBA 01/2011
1	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2009
1	Rosuvastatin Calcium (Crestor)FDA Link 09/2009
1	Antihypertensive Agents (Antihypertensives)IBA 07/2009
1	Fatty Acid-Binding ProteinsIBA 01/2009
1	Simvastatin (Zocor)FDA LinkGeneric 12/2008
1	Sirolimus (Rapamycin)FDA Link 01/2008
1	Losartan (Cozaar)FDA LinkGeneric 01/2007
1	CXCR ReceptorsIBA 01/2006
1	Carvedilol (Coreg)FDA LinkGeneric 01/2006
1	CC ChemokinesIBA 01/2006
1	Arginine (L-Arginine)FDA Link 01/2006
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2006

Therapy/Procedure

16	Stents 02/2018 - 01/2005
11	Therapeutics 12/2020 - 07/2002
9	Percutaneous Coronary Intervention 01/2018 - 01/2009
3	Renal Dialysis (Hemodialysis) 02/2018 - 01/2004
3	Drug-Eluting Stents 01/2017 - 02/2013
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2012 - 02/2007
2	Glycemic Control 05/2015 - 01/2011
1	Secondary Prevention 12/2020
1	Cardiac Rehabilitation 12/2014
1	Injections 01/2013
1	Aftercare (After-Treatment) 04/2012
1	Bed Rest (Bedrest) 01/2008